Core Viewpoint - The approval of Shenzhen Dapu Microelectronics Co., Ltd. (Dapu Micro) for its IPO marks the first instance of an unprofitable company listing on the ChiNext board, reflecting a significant shift in the A-share market's approach to innovative tech firms [1][7]. Group 1: Company Overview - Dapu Micro, established in 2016, specializes in the research and sales of enterprise-level SSD products, being one of the few domestic providers with comprehensive self-research capabilities in "controller chips + firmware algorithms + modules" [4]. - The company has achieved a fourth-place ranking in the domestic enterprise SSD market with a market share of 6.4%, indicating a gradual increase in domestic production [4][6]. Group 2: Financial Performance - Dapu Micro reported revenues of 5.57 billion yuan, 5.19 billion yuan, and 9.62 billion yuan from 2022 to 2024, with net losses of 5.34 billion yuan, 6.17 billion yuan, and 1.91 billion yuan respectively. The company anticipates a significant revenue growth of 88.73% in 2024 and aims to achieve profitability by 2026 [5]. - The company has invested heavily in R&D, with a total of 7.37 billion yuan spent over three years, accounting for 36.15% of total revenue [5]. Group 3: IPO Details - Dapu Micro plans to raise approximately 1.878 billion yuan through its IPO, focusing on the development and industrialization of next-generation controller chips and enterprise-level SSDs, as well as establishing a mass production testing base [5]. - The company was valued at 6.81 billion yuan during its last funding round in December 2024, highlighting its growth potential in the semiconductor sector [6]. Group 4: Industry Context - The approval of Dapu Micro's IPO under the new unprofitable listing standard is expected to pave the way for more tech innovation companies to access the A-share market, enhancing the capital landscape for early-stage firms [8]. - The increasing demand for domestic enterprise-level SSDs is driven by national security concerns and the need for self-sufficiency in critical digital infrastructure components [6].

Core Insights - The A-share IPO market in 2025 marked a historic turning point, with a significant recovery in capital market financing functions, achieving an IPO financing amount of 131.77 billion yuan, a year-on-year increase of over 90% [1][3] - The year also saw a rational return in issuance pricing, with the first "zero break" record under the comprehensive registration system, as none of the 116 companies listed in 2025 experienced a break [1][10] - The merger of Guotai Junan and Haitong Securities created a new "super giant" in the investment banking sector, challenging CITIC Securities' leading position [1][18] IPO Market Overview - The 2025 A-share IPO market was characterized by inclusivity, particularly in the acceptance of high-quality projects and unprofitable companies [3] - The top 14 IPO projects accounted for a significant portion of the total financing, indicating a concentration of capital in large projects [3] - Notable IPOs included Huadian New Energy, which raised 18.17 billion yuan, and Moer Thread, which raised 8 billion yuan, among others [4] Major Upcoming IPOs - Two companies currently under review, Changxin Technology and China Resources New Energy, are expected to raise over 10 billion yuan each, with Changxin Technology's IPO potentially becoming the second-largest in the history of the Sci-Tech Innovation Board [5][7] - Changxin Technology's application process has progressed rapidly, being the first to receive pre-review approval [5] Changes in Pricing and Performance - The median price-to-earnings ratio for new stocks in 2025 was 17 times, significantly lower than the 33 times and 34 times seen in 2022 and 2023, respectively [13] - The overall IPO financing amount of 131.77 billion yuan in 2025 was only about a quarter of the peak levels seen in 2022 and approximately 30% of the amount in 2023 [9][8] - The year 2025 also recorded a significant reduction in the number of companies that raised less than their expected amounts, with 74 companies collectively raising 10 billion yuan less than anticipated [11] Investment Banking Landscape - CITIC Securities maintained its leading position in IPO underwriting with a total of 21.88 billion yuan, followed closely by Guotai Haitong with 18.69 billion yuan [19][26] - The "100 billion underwriting club" expanded to five firms, with CITIC Securities, Guotai Haitong, and others competing for top positions [19] - The competition for "star projects" was crucial, with CITIC Securities successfully securing major deals while Guotai Haitong lagged behind [20][21] Future Outlook - The investment banking sector is expected to see continued growth in 2026, with several large IPOs on the horizon, including those from Changxin Technology and China Resources New Energy [25] - The shift towards a focus on large projects rather than quantity indicates a changing landscape in IPO underwriting strategies [25]

Group 1 - The recent surge in IPO applications in the Shanghai, Shenzhen, and Beijing stock exchanges is noted, with 29 companies receiving acceptance from December 25 to December 29, including 9 from the Beijing Stock Exchange and 9 from the ChiNext [1] - Among the accepted IPOs, several companies that previously failed to go public, such as Gaokai Technology, are making another attempt, with Gaokai aiming to raise approximately 1.5 billion yuan for semiconductor equipment development [1] - Two banks, Dongguan Bank and Nanhai Rural Commercial Bank, have resumed their IPO processes after being halted due to outdated financial documents, with Dongguan Bank having submitted its IPO application over 17 years ago [2] Group 2 - The current batch of accepted IPOs includes unprofitable companies, such as Xinnowei, which has accumulated losses of 1.65 billion yuan over the past three and a half years and plans to raise 2.94 billion yuan [2] - The increase in IPO applications at the end of the year is attributed to the financial report updates, as companies aim to submit their applications before the six-month validity period of their financial statements expires [3] - Looking ahead to 2026, the A-share market is expected to see steady growth in both the number of issuances and financing amounts, particularly for companies in priority development sectors such as AI, new energy, and high-end manufacturing [3]

Core Viewpoint - Shenzhen Dapu Microelectronics Co., Ltd. has become the first unprofitable company to pass the review for IPO on the ChiNext board, marking a significant milestone in the history of the board [1][2] Group 1: IPO and Funding - Dapu Micro plans to issue up to 43.62 million shares, raising approximately 1.878 billion yuan, with funds allocated to three main projects: R&D and industrialization of next-generation main control chips and enterprise-level SSDs (955 million yuan, 51%), mass production testing base for enterprise-level SSD modules (220 million yuan, 12%), and working capital (700 million yuan, 37%) [2] - The company adopted the second set of listing standards for the ChiNext board, requiring an expected market value of no less than 5 billion yuan and a recent year's revenue of no less than 500 million yuan [2] Group 2: Financial Performance - The company's revenue for 2022-2024 is projected to be 557 million yuan, 519 million yuan, and 962 million yuan, respectively, with net losses of 368 million yuan, 642 million yuan, and 195 million yuan during the same period [3] - In the first half of 2025, revenue is expected to reach 748 million yuan with a loss of 354 million yuan, while the first three quarters are projected to generate 1.264 billion yuan in revenue with a loss of 442 million yuan, totaling a cumulative loss of 1.566 billion yuan over three and a half years [3] Group 3: Market Position and Clients - Dapu Micro is a leading provider of semiconductor storage products in China, specializing in the R&D and sales of enterprise-level SSDs, with a full-stack self-research capability in main control chips, firmware algorithms, and modules [5][10] - The company has established a strong client base, including major internet companies like ByteDance, Tencent, Alibaba, and telecommunications giants such as China Telecom, China Mobile, and China Unicom [10] Group 4: Innovation and Patents - As of June 30, 2025, Dapu Micro has been granted 156 invention patents, including 88 core circuit patents, and has filed over 300 invention patents [9][10] - The company’s technology in enterprise-level SSDs is considered industry-leading, with a market share of 6.7% in 2024, despite the overall market for enterprise-level SSDs in China being dominated by foreign brands [10]

Core Viewpoint - The IPO acceptance process is accelerating as the year-end approaches, with a total of 19 IPO applications accepted in December, primarily by the Shanghai and Shenzhen stock exchanges, indicating a robust growth in the A-share market for new listings in 2025 [1][3][9]. Group 1: IPO Acceptance and Market Trends - From December 22 to 24, seven companies, including Boma Medical and Siyi Technology, had their IPO applications accepted, with the Shanghai Stock Exchange accepting three and the Shenzhen Stock Exchange four [3]. - As of December 24, the total number of IPOs accepted in December reached 19, with the Shanghai and Shenzhen exchanges accounting for nearly 80% of these [1][3]. - The A-share market is expected to see 114 new IPOs in 2025, representing a 14% increase compared to the previous year [1][9]. Group 2: Company Specifics and Financials - Among the newly accepted IPOs, four companies, including Yuanchip Semiconductor and Guoyi Quantum, are notable for their high-tech focus and are applying for listings despite reporting losses [6][7]. - Yuanchip Semiconductor aims to raise approximately 7.5 billion yuan, making it the largest fundraising among the new IPOs [4][6]. - Other companies with proposed fundraising over 1 billion yuan include Xinowei and Boma Medical, with Xinowei's fundraising amounting to 2.94 billion yuan [4]. Group 3: Market Dynamics and Future Outlook - The acceptance of IPOs from unprofitable companies is seen as a way to enrich the market structure and provide high-growth investment opportunities [7]. - The overall fundraising amount from new IPOs this year has significantly increased, with 111 new stocks raising approximately 125.32 billion yuan, compared to 67.35 billion yuan last year [9][10]. - Deloitte's report anticipates that by the end of 2025, the A-share market will see 114 companies listed, raising 129.6 billion yuan, with a focus on sectors prioritized in China's development plans [10][11].

Group 1 - The core viewpoint of the news is that the IPO acceptance process is accelerating, with a total of 19 IPO applications accepted in December, primarily by the Shanghai and Shenzhen stock exchanges, indicating a robust market for new listings [1][3] - Among the newly accepted IPOs, four companies, including Yuexin Semiconductor and Guoyi Quantum, are notable for their high-tech focus and are applying for listings despite being in a loss position [1][6] - The A-share market is expected to see 114 new listings in 2025, representing a 14% increase compared to the previous year, with a significant rise in total fundraising amounts [1][9] Group 2 - In the recent acceptance period from December 22 to 24, seven companies, including Boma Medical and Siyi Technology, had their IPO applications accepted, with the Shanghai Stock Exchange accepting three and the Shenzhen Stock Exchange accepting four [3] - Yuexin Semiconductor leads the proposed fundraising amounts with approximately 7.5 billion yuan, focusing on providing 12-inch wafer foundry services [3][4] - The trend of accepting IPOs from unprofitable companies is supported by recent regulatory changes aimed at fostering innovation, allowing for a more diverse range of companies to enter the market [6][8] Group 3 - The total fundraising amount for new IPOs in the A-share market has significantly increased, with 111 new stocks raising approximately 125.32 billion yuan this year, compared to 67.35 billion yuan last year [9][10] - The largest IPO this year is Huadian New Energy, raising 18.17 billion yuan, followed by Moer Thread and Xi'an Yicai with 8 billion yuan and 4.64 billion yuan respectively [10] - The report from Deloitte anticipates that by the end of 2025, the A-share market will have 114 companies listed, with a total financing of 129.6 billion yuan, indicating a positive outlook for the IPO market [11]

Core Viewpoint - The news highlights the upcoming IPO application of Guangdong-based Yu Xin Semiconductor Technology Co., Ltd. (referred to as "Yu Xin Semiconductor"), marking it as the second unprofitable company to apply for an IPO on the ChiNext board, following Da Pu Wei. Unlike Da Pu Wei, which expects to turn profitable by 2026, Yu Xin Semiconductor anticipates achieving profitability by 2029, raising concerns about its financial sustainability and potential delisting risks due to its unprofitable status [1][9]. Group 1: Company Overview - Yu Xin Semiconductor provides 12-inch wafer foundry services and specialized process solutions for chip design, with applications in consumer electronics, industrial control, automotive electronics, and artificial intelligence [2]. - The company operates two 12-inch wafer fabs with a combined planned capacity of 80,000 wafers per month and plans to build a third fab with an additional capacity of 40,000 wafers per month, bringing the total to 120,000 wafers per month upon completion [2]. - The company's shareholder structure is diverse, with no single controlling shareholder, and major shareholders include Yu Xin Zhong Cheng (16.88%), Guangdong Semiconductor Fund (11.29%), and others [2]. Group 2: Financial Performance - Yu Xin Semiconductor's revenue for the reporting period (2022 to mid-2025) is projected to be 1.545 billion, 1.044 billion, 1.681 billion, and 1.053 billion yuan, with a significant year-on-year revenue decline of 32.46% in 2023, followed by a projected growth of 61.09% in 2024 [3]. - The company has reported increasing net losses, with figures of 1.043 billion, 1.917 billion, 2.253 billion, and 1.2 billion yuan, indicating a trend of escalating financial losses [3]. - As of the end of the reporting period, the company had accumulated undistributed losses of 8.936 billion yuan, reflecting its ongoing financial challenges [3]. Group 3: Industry Context - The semiconductor industry is characterized by strong cyclicality influenced by global economic fluctuations, demand changes in downstream markets, and inventory cycles [5]. - The industry has entered a downcycle due to global economic downturns and geopolitical conflicts, with a recovery expected in 2024, as indicated by rising consumer electronics indicators [6]. - Yu Xin Semiconductor's sales revenue from integrated circuit foundry products decreased by 40.70% in 2023, with a sales price drop of 32.32%, but is expected to recover in 2024 with over 70% growth in both sales revenue and volume [6]. Group 4: Financial Risks - The company's asset-liability ratio reached 76.08%, significantly higher than the industry average, primarily due to high fixed costs and reliance on bank and shareholder loans for funding [7]. - Yu Xin Semiconductor's R&D expense ratio is notably high, averaging 37.28% to 57.31% during the reporting period, reflecting its focus on innovation despite financial losses [7]. - The company faces potential delisting risks if it fails to meet the financial criteria set by the ChiNext board, including negative net profit and insufficient revenue [9].

Core Viewpoint - Yuanchip Semiconductor Technology Co., Ltd. has applied for A-share listing on the ChiNext board, following the trend of unprofitable companies seeking public funding under new listing standards [1][4]. Group 1: Company Overview - Yuanchip Semiconductor is a 12-inch chip manufacturing company that has fully entered mass production, starting from consumer chip manufacturing and gradually upgrading to industrial electronics [2][3]. - The company currently operates two 12-inch wafer fabs with a combined planned capacity of 80,000 wafers per month, with plans to add a new production line that will increase total capacity to 120,000 wafers per month [3]. Group 2: Financial Information - Yuanchip Semiconductor plans to raise 7.5 billion yuan (approximately $1.06 billion) through its IPO, which will be used for the development of a 12-inch integrated circuit analog specialty process production line, technology platform research, and to supplement working capital [3]. - The company has reported significant losses over the past few years, with losses of 1.043 billion yuan, 1.917 billion yuan, 2.253 billion yuan, and 1.201 billion yuan for the years 2022, 2023, 2024, and the first half of 2025, respectively, totaling 6.414 billion yuan [3]. Group 3: Listing Standards and Regulatory Environment - The listing standard chosen by Yuanchip Semiconductor is based on the revised rules of the Shenzhen Stock Exchange, which require a market value of no less than 5 billion yuan and a minimum revenue of 300 million yuan in the most recent year [3]. - The introduction of the third set of listing standards on the ChiNext board aims to support high-quality, unprofitable innovative companies in accessing capital markets [4].

Group 1: Market Trends - In October 2025, 11 new stocks were issued in the A-share market, raising a total of 15.3 billion yuan, a 29% increase month-on-month[10] - The average first-day closing price increase for new stocks in the Shanghai and Shenzhen markets was 235%, up 28.2 percentage points from the previous month[28] - The average first-day increase for three unprofitable new stocks was 162%[28] Group 2: Pricing and Allocation Mechanism - The average first-day price-earnings (PE) ratio for new stocks was 25 times, reaching a monthly peak for the year, but still at a 34% discount compared to comparable companies[13] - The A1 allocation tier saw an average winning rate of 0.073%, a 76% increase compared to previous periods, while the A2 tier's winning rate dropped to 0.026%, a 38% decrease[19] - The new stock pricing and allocation mechanism is being optimized to encourage long-term holding, with higher allocation ratios for investors committing to longer lock-up periods[6] Group 3: Growth in Specific Sectors - The first batch of new stocks in the Sci-Tech Innovation Board's growth tier raised a total of 8.8 billion yuan in October 2025[10] - The inquiry results showed that the first three growth tier new stocks attracted an average of 6,691 product participants, an increase of 8.6% compared to June[19] - The total number of IPO projects in the A-share market reached 114, with a total proposed fundraising amount of 207.8 billion yuan as of the end of October 2025[54] Group 4: Risks and Challenges - Risks include potential changes in the pace of new stock issuance reviews, fluctuations in investor participation, and the quality and quantity of submitted projects[57] - There is a need to monitor the structural adjustments in industries and the risk of unprofitable companies facing share price declines[57]

Core Viewpoint - The listing of three unprofitable companies on the Sci-Tech Innovation Board marks a significant step in providing a platform for high-quality unprofitable tech enterprises, enhancing their predictability in going public [1] Group 1: Listing and Market Response - Three unprofitable companies, Wuhan Heyuan Biotechnology Co., Ltd., Xi'an Yiswei Material Technology Co., Ltd., and Guangzhou Bibete Pharmaceutical Co., Ltd., have officially listed on the Sci-Tech Innovation Board, increasing the total number of companies on the board to 592 [1] - The Shanghai Stock Exchange's revised rules in March allow unprofitable companies to adopt differentiated lock-up periods, encouraging institutional investors to play a larger role in new stock pricing [2] - The enthusiasm of institutional investors is reflected in the high subscription rates for the differentiated lock-up tiers, with A1 and A2 tiers accounting for over 70% of the total subscription volume for Heyuan Biotechnology [2][3] Group 2: Company Perspectives - Xi'an Yiswei's chairman emphasized that the initial losses are part of a necessary process for technological breakthroughs and that the listing is a milestone for the company, enabling it to enhance its core competitiveness [4] - Heyuan Biotechnology's chairman stated that the listing on the Sci-Tech Innovation Board is crucial for accelerating the company's industrialization process and improving its competitive capabilities [5] Group 3: Capital Market Dynamics - The establishment of the Sci-Tech Innovation Board's growth tier is expected to attract more patient capital into the technology sector, enhancing the confidence of tech companies and stimulating investment enthusiasm in the venture capital industry [6] - The new policies are set to inject vitality into the index system, providing a solid foundation for developing targeted indices focused on unprofitable high-R&D enterprises [6] - The improved market structure and transparency are anticipated to create a better investment environment for long-term and patient capital, promoting a virtuous cycle between technology, industry, and capital [6]